Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
19,341,215
-
Share change
-
-816,920
-
Total reported value
-
$13,101,541
-
Price per share
-
$0.68
-
Number of holders
-
45
-
Value change
-
-$455,489
-
Number of buys
-
20
-
Number of sells
-
29
Institutional Holders of THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) as of Q3 2016
As of 30 Sep 2016,
THRESHOLD PHARMACEUTICAL INC - COM NEW (THLD) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,341,215 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT CO, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Cormorant Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, and KCG Holdings, Inc..
This page lists
45
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.